Phase 2 Modular Peptide System B+D

Description

Phase 2 Modular Peptide System B+D

The Phase 2 Modular Peptide System B+D is a multi-peptide research configuration combining two distinct formulation architectures within one structured research system.

The configuration brings together Module B, a concentrated dual-peptide gel, and Module D, an AHK-Cu copper-peptide formulation.

This creates a research framework containing different peptide structural characteristics and formulation environments, allowing researchers to evaluate peptide composition, analytical properties, formulation behavior, and stability under controlled laboratory conditions.

The documented Module B formulation contains Palmitoyl Tripeptide-38 at 0.20% and Palmitoyl Tetrapeptide-7 at 0.03%, for a stated total peptide content of 0.23%. It is described as a 20 mL peptide gel with a pH range of 5.0–6.0.

For LV Longevity Peptides, the numerical specifications should be published only after verification against the current LV formulation and batch documentation.

---

Module B — Concentrated Dual-Peptide System

Module B provides the first component of the Phase 2 configuration.

Documented composition

• Palmitoyl Tripeptide-38: 0.20%
• Palmitoyl Tetrapeptide-7: 0.03%
• Total peptide content: 0.23%
• Formulation: Peptide gel
• Volume: 20 mL
• pH: 5.0–6.0

The formulation is characterized by a dual-peptide architecture with Palmitoyl Tripeptide-38 as the dominant peptide component.

For the LV page, these values should be treated as reference specifications until confirmed against LV’s own product documentation.

Module D — AHK-Cu Copper-Peptide System

Module D provides the second component of the Phase 2 configuration.

AHK-Cu is a copper-coordinated peptide complex and therefore introduces a different chemical structure from the palmitoylated peptide components in Module B.

The documented Module D formulation is classified as a copper-peptide serum-emulsion and contains AHK-Cu as its primary peptide component.

For LV, publish the exact AHK-Cu concentration, formulation volume, pH, supporting ingredients, and packaging specifications only from the current LV documentation.

---

Phase 2 Research Architecture

The B+D configuration creates an especially useful analytical comparison between two different peptide formulation environments:

Module B

Palmitoylated peptide + palmitoylated peptide → concentrated peptide gel

Module D

Copper-coordinated peptide → copper-peptide serum-emulsion

This allows the product to be described around several research variables:

• peptide structural class
• peptide concentration
• formulation matrix
• peptide-metal coordination
• gel versus emulsion systems
• analytical characterization
• formulation stability
• peptide compatibility

---

Research Applications

Peptide Composition Research

Evaluate peptide identity, composition, concentration, and formulation characteristics within a controlled multi-module system.

Analytical Characterization

Support laboratory analysis of peptide-containing formulations using appropriate analytical techniques.

Formulation Stability Research

Investigate the stability characteristics of different peptide formulations under controlled laboratory conditions.

Peptide Compatibility Studies

Evaluate interactions and compatibility between peptide components and their respective formulation environments.

Copper-Peptide Research

Module D provides an AHK-Cu-containing formulation for research involving copper-coordinated peptide systems.

Comparative Formulation Research

The B+D configuration allows researchers to examine differences between a concentrated dual-peptide gel and a copper-peptide formulation.

---

Product Specifications